Impact of the European Clinical Trials Directive on prospective academic clinical trials associated with BMT

Frewer, L. J.; Coles, D.; van der Lans, I. A.; Schroeder, D.; Champion, K.; Apperley, J. F.
March 2011
Bone Marrow Transplantation;Mar2011, Vol. 46 Issue 3, p443
Academic Journal
The European Clinical Trials Directive (EU 2001; 2001/20/EC) was introduced to improve the efficiency of commercial and academic clinical trials. Concerns have been raised by interested organizations and institutions regarding the potential for negative impact of the Directive on non-commercial European clinical research. Interested researchers within the European Group for Blood and Marrow Transplantation (EBMT) were surveyed to determine whether researcher experiences confirmed this view. Following a pilot study, an internet-based questionnaire was distributed to individuals in key research positions in the European haemopoietic SCT community. Seventy-one usable questionnaires were returned from participants in different EU member states. The results indicate that the perceived impact of the European Clinical Trials Directive has been negative, at least in the research areas of interest to the EBMT.


Related Articles

  • Clinical Trial Registration. Laine, Christine; Horton, Richard; DeAngelis, Catherine D.; Drazen, Jeffrey M.; Frizelle, Frank A.; Godlee, Fiona; Haug, Charlotte; H├ębert, Paul C.; Kotzin, Sheldon; Marusic, Ana; Sahni, Peush; Schroeder, Torben V.; Sox, Harold C.; Van Der Weyden, Martin B.; Verheugt, Freek W.A. // JAMA: Journal of the American Medical Association;7/4/2007, Vol. 298 Issue 1, p93 

    The authors reflect on the state of clinical trial registration. In 2005, the International Committee of Medical Journal Editors (ICMJE) initiated a policy which required medical investigators to disclose date related to clinical trial designs to a clinical trials registry prior to the...

  • India's next challenge: Rebooting recruitment. Bhatt, Arun // Perspectives in Clinical Research;Jul-Sep2014, Vol. 5 Issue 3, p93 

    The article presents the author's views on recruitment in the clinical trial industry in India. According to report, only 30% of patients in India are likely give consent for clinical trial. The author states that while regulatory scenario improves in India, the industry should refocus on...

  • INSTITUTE IN PHILADELPHIA TO PARTICIPATE IN A CLINICAL TRIAL.  // Journal of Visual Impairment & Blindness;May2012, Vol. 106 Issue 5, p315 

    No abstract available.

  • Neural Stem Cell Success.  // American Scientist;Jan/Feb2013, Vol. 101 Issue 1, p29 

    The article discusses a clinical trial in which neural stem cells were implanted into the brains of young boys to produce myelin and increase motor function suffering as the result of a chromosome disorder.

  • Revisiting the European Union Directive in CEE. Capala-Szczurko, Iwona // Applied Clinical Trials;Mar2006, Vol. 15 Issue 3, p56 

    No abstract available.

  • EU Trials Come Under Scrutiny. Ward, Philip // Applied Clinical Trials;Mar2010, Vol. 19 Issue 3, p18 

    The article focuses on the legislative environment of clinical trials and researchers in the European Union (EU). It mentions the issued statement of European Forum for Good Clinical Practice (EFGCP) with regards to the important trials that were not performed due to the related costs and...

  • Great Expectations: CROs Face Change in Italy. Corrado, Mario // Applied Clinical Trials;Nov2009, Vol. 18 Issue 11, p50 

    The article reports on the turbulent period of the clinical trials in Italy. It states that the country has a heterogeneous topology of the Contract Research Organizations (CRO) while the number of new trials per year has increased consistently from 500 in 2000 to 800 in 2007. On the other hand,...

  • The Unintended Consequences of Clinical Trials Regulations. McMahon, Alex D.; Conway, David I.; MacDonald, Tom M.; McInnes, Gordon T. // PLoS Clinical Trials;Nov2009, Vol. 6 Issue 11, Special section p1 

    The article discusses the negative impact of clinical trials regulations on noncommercial research and patients. Particular focus is given to regulations imposed by the European Union (EU) which are incorporated into the British national law on Good Clinical Practice (GCP). The EU GCP Directive...

  • India Will Fast-Track Clinical Trial Approvals. Harachand, S. // Contract Pharma;Sep2014, Vol. 16 Issue 7, p32 

    The article reports on Indian government's plans to fast-track clinical trial approvals. A series of new rules as a result of a Supreme Court of India judgment in early January 2013, which ordered the government to ensure patient safety in clinical research, led to enhanced regulatory activity....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics